DreaMed
By DreaMed Diabetes, Ltd.
DreaMed Intelligence Room
See. Share. Shape.
Every post on social media is buried the next day. Not here. Signals become memory, and memory becomes intelligence.
Share your experience about DreaMed
HealthAratus Reality Window
DreaMed
DreaMed Diabetes, Ltd. · Clinical Chemistry · HAS 1
No Primary Value Claim has been stated for this Tool.
FDA authorization is regulatory memory. It does not establish real-world effectiveness.
Still unknown
- DreaMed Diabetes, Ltd. has not stated a Primary Value Claim.
- No independently observed deployment yet.
- Independent evidence is sparse.
Governed by HealthAratus. The company may share this Window but cannot edit it. Full Tool page
What HealthAratus sees
The question reality is answering.
Forming
HealthAratus is forming the question DreaMed's reality needs answered.
Human reality
What users are seeing.
Gathering
The first real accounts of DreaMed are still being gathered.
Tool intelligence
What HealthAratus understands
HealthAratus currently understands DreaMed through regulatory records, company records and external market activity.
- Category
- clinical-chemistry
What HealthAratus is still learning
HealthAratus is beginning to understand DreaMed. As evidence and experience accumulate, what remains unclear will be stated here.
FDA regulatory history
What regulators have authorized.
2
regulatory decisions
2018
first known authorization
2019
latest regulatory activity
Product families: DreaMed
- DreaMed Advisor Pro510(k) · K191370 · 2019-07-18
- DreaMed Advisor ProDe Novo · DEN170043 · 2018-06-12
FDA-authorized. No HealthAratus user Signals yet. Authorization is not adoption.
Seen DreaMed in practice?
Category ranking
clinical chemistry
10+ tools observed
- 1BarreleyestableDeveloping
- 2DreaMedstableDeveloping
- 3VitestrocoolingDeveloping
DreaMed is ranked number 2 in clinical chemistry by HealthAratus Score). Rankings will change as more intelligence comes in, so follow DreaMed to see all changes.
See. Share. Shape.